Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Asset Utilization Ratio (2016 - 2025)

Seres Therapeutics' Asset Utilization Ratio history spans 10 years, with the latest figure at 0.01 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 2537.73% year-over-year to 0.01; the TTM value through Sep 2025 reached 0.01, up 2537.73%, while the annual FY2023 figure was 0.36, 1662.86% up from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.01 at Seres Therapeutics, up from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.46 in Q2 2022 and bottomed at 0.0 in Q3 2024.
  • The 5-year median for Asset Utilization Ratio is 0.04 (2021), against an average of 0.17.
  • The largest annual shift saw Asset Utilization Ratio crashed 99.92% in 2024 before it soared 2537.73% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.39 in 2021, then crashed by 94.41% to 0.02 in 2022, then skyrocketed by 1525.37% to 0.35 in 2023, then crashed by 98.89% to 0.0 in 2024, then skyrocketed by 73.87% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for MCRB's Asset Utilization Ratio are 0.01 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025).